Results 41 to 50 of about 37,373 (211)

Development of nucleic acid-based vaccines against dengue and other mosquito-borne flaviviruses: the past, present, and future

open access: yesFrontiers in Immunology
Due to their widespread geographic distribution and frequent outbreaks, mosquito-borne flaviviruses, such as DENV (DENV), Zika virus (ZIKV), Japanese encephalitis virus (JEV), yellow fever virus (YFV), and West Nile virus (WNV), are considered ...
Muhammad Bashir Bello   +6 more
doaj   +1 more source

Changing Ecotypes of Dengue Virus 2 Serotype in Nigeria and the Emergence of Cosmopolitan and Asian I Lineages, 1966–2019

open access: yesVaccines, 2023
Dengue virus (DENV) is a leading mosquito-borne virus with a wide geographical spread and a major public health concern. DENV serotype 1 (DENV-1) and serotype 2 (DENV-2) were first reported in Africa in 1964 in Ibadan, Nigeria.
Bernard A. Onoja   +4 more
doaj   +1 more source

Preliminary survey of dengue, Zika and chikungunya viruses by nucleic acid test in blood donors in Shenzhen, China

open access: yesFrontiers in Public Health
ObjectiveTo investigate the prevalence of dengue virus (DENV), Zika virus (ZIKV), and chikungunya virus (CHIKV) in blood donors and to preliminarily assess the potential risk of arbovirus transmission through blood transfusion in Shenzhen, China ...
Xin Zheng   +10 more
doaj   +1 more source

DENV-2 RNA levels increase WT and SK1-/- mice following ic DENV infection.

open access: yes, 2017
WT and SK1-/- mice were ic infected with DENV, as in Fig 1. RNA was isolated from infected mice brain tissues and analysed by real time qRT-PCR for DENV. A. Total DENV-2 RNA increases with time in WT mice, n = 3 at each time point; B.
Jennifer N. Clarke (403889)   +5 more
core   +1 more source

Molecular virology profiles of dengue cases in Bandung, Indonesia

open access: yesJournal of Vector Borne Diseases
Background & objectives: Bandung City, West Java, Indonesia, is a hyperendemic area for dengue virus (DENV) infections. However, data on virus distribution in this area is currently limited.
Nisa Fauziah   +6 more
doaj   +1 more source

DENV and ZIKV detection in patients with acute febrile syndrome in Córdoba, Colombia

open access: yesInternational Journal of Infectious Diseases, 2020
Objective: To determine simultaneous circulation of DENV serotypes and ZIKV in Córdoba, Colombia, during 2015 and 2016. Material and methods: A total of 294 samples from patients with clinical diagnosis of febrile syndrome compatible with dengue were ...
Paula A. Avilés-Vergara   +6 more
doaj   +1 more source

DENV-3 plasmid starting library.

open access: yes, 2017
DENV-3 antigen fragment plasmid library was assessed by Ion Torrent Deep Sequencing to determine coverage at each amino acid position. (A) Deduced peptide sequences were aligned to the DENV-3 polyprotein with NCBI BLAST and used to determine the coverage
Kathryn M. Frietze (3713686)   +4 more
core   +1 more source

Production of dengue virus-like particles serotype-3 in silkworm larvae and their ability to elicit a humoral immune response in mice

open access: yesAMB Express, 2020
To develop monovalent dengue virus-like particle for serotype 3 (DENV-LP/3), we prepared and expressed two structural polyprotein constructs using silkworm and Bm5 cells: DENV-3 Capsid-premembrane-envelope (DENV-3CprME) and premembrane-envelope (DENV ...
Doddy Irawan Setyo Utomo   +4 more
doaj   +1 more source

DENV-2 infection rate of Ae. albopictus.

open access: yes, 2022
The experiment was divided into two groups, the simulated field environment group and the standard laboratory environment group. The simulated field environment groups was classed into simulated in summer and winter. Three factors, temperature, humidity,
Yong Wei (44544)   +7 more
core   +1 more source

In silico design of a multi-epitope vaccine targeting DENV-1 and DENV-3

open access: yesScientific Reports
Abstract The co-infection of DENV-1 and DENV-3 during endemic outbreaks can be potentially fatal and complicate the diagnostic process. In our study, we have focused on the development of a multiepitope vaccine against DENV-1 and DENV-3 co-infection, utilizing non-structural protein 1 (NS1) and envelope protein (E)
Ishwar, Deepthi   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy